L E Scudder - Concepedia

Author

L E Scudder

Stony Brook University

Also Known As

L E Scudder, L. Scudder, L.E. Scudder, LESLEY E. SCUDDER, Lesley E Scudder, Lesley E. Scudder, Lesley Scudder

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

Stony Brook University State University of New York Icahn School of Medicine at Mount Sinai Harvard University Massachusetts General Hospital

About

L E Scudder is an author at Stony Brook University specializing in medicine, hematology, and vascular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	1.7K
2	Engineering	2	2	140
3	Health Sciences	2	2	140
4	Biochemistry	2	2	872
5	Natural Sciences	1	1	761

L E Scudder

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa. Barry S. Coller, Ellinor I.B. Peerschke, L E Scudder, Journal of Clinical Investigation ImmunologyMolecular BiologyInflammationThrombosisBioanalysis	1983	761
Abolition of in vivo platelet thrombus formation in primates with monoclonal antibodies to the platelet GPIIb/IIIa receptor. Correlation with bleeding time, platelet aggregation, and blockade of GPIIb/IIIa receptors. Barry S. Coller, John D. Folts, Susan R. Smith, Circulation ImmunologyPharmacotherapyPlatelet AggregationThrombosisHematology	1989	244
Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs. Tsunehiro Yasuda, Herman K. Gold, John T. Fallon, Journal of Clinical Investigation ImmunologyThrombosisHematologyPlatelet ConcentratesLeft Anterior Descending	1988	243
Thromboerythrocytes. In vitro studies of a potential autologous, semi-artificial alternative to platelet transfusions. Barry S. Coller, K. Springer, Jürg H. Beer, Journal of Clinical Investigation Mixed AggregatesEngineeringRgd PeptidesBiomedical EngineeringThrombosis	1992	111
Rapid and Simple Platelet Function Assay to Assess Glycoprotein IIb/IIIa Receptor Blockade Barry S. Coller, Daniel G. Lang, L E Scudder Circulation	1997	109
Activation of Platelets in Platelet-Rich Plasma by Rotablation Is Speed-Dependent and Can Be Inhibited by Abciximab (c7E3 Fab; ReoPro) Marlene S. Williams, Barry S. Coller, Heikki Väänänen, Circulation	1998	103
In Vitro Effects of the Platelet Glycoprotein IIb/IIIa Receptor Antagonist c7E3 Fab on the Activated Clotting Time Tameshwar Ammar, L E Scudder, Barry S. Coller Circulation	1997	90
Evidence that glycocalicin circulates in normal plasma. Barry S. Coller, E L Kalomiris, M Steinberg, Journal of Clinical Investigation GlycobiologyImmunologyPathologyPlasma MedicineCellular Physiology	1984	79
Thrombin receptor activating peptides: importance of the N-terminal serine and its ionization state as judged by pH dependence, nuclear magnetic resonance spectroscopy, and cleavage by aminopeptidase M Barry S. Coller, Patrick E. Ward, M Ceruso, Biochemistry	1992	61
Thrombus radioimmunoscintigraphy: an approach using monoclonal antiplatelet antibody. Z.H. Oster, S.C. Srivastava, P. Som, Proceedings of the National Academy of Sciences ImmunologyPlatelet-bound RadioactivityPathologyImmunotherapyThrombosis	1985	61

Page 1